OABI Stock Analysis: Buy, Sell, or Hold?
OABI - OmniAb, Inc. Common Stock
$1.54
-0.02 (-1.28%)
▼
5d:
-2.53%
30d:
-14.92%
90d:
-16.76%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When OABI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OABI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OABI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OABI is currently trading at $1.54, which is considered oversold relative to its 30-day fair value range of $1.62 to $1.90.
Technical Outlook: Technically, OABI is showing sideways momentum. Immediate support is located at $1.47, while resistance sits at $1.84.
Market Sentiment: OABI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.33 (+376.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OABI is showing sideways momentum. Immediate support is located at $1.47, while resistance sits at $1.84.
Market Sentiment: OABI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.33 (+376.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.62 -
$1.90
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 376.2% below Wall St target ($7.33)
Fair Price Analysis
30-Day Fair Range
$1.62 -
$1.90
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.47
Resistance Level
$1.84
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.13
Wall Street Target
$7.33
(+376.2%)
Revenue Growth (YoY)
-22.5%
Share & Embed Analysis
Last updated: April 05, 2026 6:38 PM ET
Data refreshes hourly during market hours. Next update: 7:38 PM
Data refreshes hourly during market hours. Next update: 7:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OABI showing a specific setup today?
Insider Activity (6 Months)
2
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Kurt A Gustafson
SELL
9301 shares
2026-02-18
Matthew W Foehr
SELL
30843 shares
2026-02-18
Charles S Berkman
SELL
9673 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 58 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 60 HOLD |
